Clinical trial
A Proof of Concept Study Assessing the Effect of Four Different Single Bolus…
NCT00209326 · Ferring Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00209326 |
|---|---|
| Title | A Proof of Concept Study Assessing the Effect of Four Different Single Bolus Intravenous Doses of FE200440 and Placebo on Stopping Preterm Labor |
| Official title | A Randomised, Double-blind, Parallel Group, Dose-ranging, Placebo-controlled, Multi-centre, Proof of Concept Study Assessing the Effect of Four Different Single Bolus Intravenous Doses of FE200440 (0.3, 1, 3, 10 mg) and Placebo on Stopping Preterm Labour and Uterine Contractions in Pregnant Women… |
| Lead sponsor | Ferring Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Labor, Premature, Premature Birth |
| Intervention type | Drug |
| Interventions | FE200440 |
| Enrollment | 163 |
| Start date | Nov 1, 2003 |
| Primary completion | Jul 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Sep 21, 2005 |
| Last update posted | Dec 16, 2011 |
| Countries | Belgium, Czechia, Finland, Lithuania, Poland, Romania |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: